Companies / TuHURA Biosciences, Inc./NV

TuHURA Biosciences, Inc./NV

Nasdaq: HURACIK 1498382TAMPA, FL

Financials · FY2025

Revenue$0
Net income$-30.05M
Total debt$265
Cash$6.30M
Diluted EPS$-0.63
Shares outstanding63.7M

Ownership

63.7M shares outstanding · as of May 12, 2026
3.4%Insiders
Ownership
Insiders3.41%2,173,307
Institutions10.22%6,510,541
Public float86.36%54,998,680

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 7

View all →
Insider% of sharesShares
Bianco James A.CEOChief Executive Officer · Director
3.41%2,173,307
Dearborn DanChief Financial Officer
List AlanDirector
Ng George KDirector

Institutional holders 70

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
May 28, 2026Bianco James A.
CEO
GiftCommon Stock$0-150K
-6.46%
2,173,307
3.41% of shares
low
Feb 12, 2026Ng George K
Director
GrantOptions (Right to Buy)+156K
156,240
0.25% of shares
low
Feb 12, 2026Tendler Craig
Director
GrantOptions (Right to Buy)+156K
156,240
0.25% of shares
low
Feb 12, 2026Manuso James S J
Director
GrantOptions (Right to Buy)+156K
156,240
0.25% of shares
low
Feb 12, 2026List Alan
Director
GrantOptions (Right to Buy)+156K
156,240
0.25% of shares
low
Feb 12, 2026Hoffman Robert E.
Director
GrantOptions (Right to Buy)+156K
156,240
0.25% of shares
low
Jan 6, 2026Dearborn Dan
Executive
GrantOptions (Right to Buy)+274K
273,696
0.43% of shares
low
Jan 6, 2026Bianco James A.
CEO
GrantOptions (Right to Buy)+610K
610,332
0.96% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Highbridge Capital Management, LLCPassive13G

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
HURACommon StockEquity898920103BBG001J7N7K8